REGENERON PHARMACEUTICALS (REGN)       693.58  +7.48 (+1.09%)

693.58  +7.48 (+1.09%)

US75886F1075 - Common Stock

MRQ
(2022-6-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
ASSETS
Current Assets
Cash Equivalents
3.40B2.89B2.19B1.62B1.47B
Treasury Stock
-9.00B-8.26B-6.61B-740.00M-396.00M
Marketable Securities
4.17B2.81B1.39B1.60B1.34B
Receivables
5.16B6.04B4.12B2.67B2.24B
Inventories
2.22B1.95B1.49B1.01B822.00M
Other Current Assets
583.60M332.40M592.00M788.00M572.00M
Total Current Assets
15.53B14.01B9.78B7.69B6.45B
 
Non-Current Assets
PPE Net
3.64B3.48B3.22B2.89B2.58B
Investments And Advances
6.46B6.88B3.19B3.31B1.80B
Other Non-Current Assets
1.57B1.06B968.00M913.00M911.00M
Total Non-Current Assets
11.68B11.42B7.38B7.12B5.29B
 
TOTAL ASSETS
27.21B25.43B17.16B14.80B11.73B
 
LIABILITIES
Current Liabilities
Short Term Debt
0.000.000.000.000.00
Accounts Payable And Accrued Liabilities
534.20M564.00M476.00M418.00M218.00M
Accrued Expenses
1.93B1.88B1.50B1.04B751.00M
Other Current Liabilities
566.30M768.30M720.00M641.00M473.00M
Total Current Liabilities
3.03B3.93B2.70B2.10B1.44B
 
Non-Current Liabilities
Long Term Debt
2.70B1.98B2.70B714.00M709.00M
Other Non-Current Liabilities
783.40M753.50M745.00M905.00M826.00M
Total Non-Current Liabilities
3.48B2.73B3.44B1.62B1.53B
 
TOTAL LIABILITIES
6.52B6.67B6.14B3.72B2.98B
 
SHAREHOLDERS' EQUITY
Additional Paid In Capital
9.12B8.09B6.72B4.43B3.91B
Shares Outstanding
109.50M108.67M107.00M110.00M109.00M
Common Shares
100.00K100.00K0.000.000.00
Retained Earnings
20.79B18.97B10.89B7.38B5.25B
Other Shareholders' Equity
-223.80M-26.20M29.00M21.00M-12.00M
Total Shareholders' Equity
20.69B18.77B11.03B11.09B8.76B
 
TOTAL LIABILITIES AND EQUITY
27.21B25.43B17.16B14.80B11.73B
 
Statistics
Debt/Equity
0.130.110.240.060.08
Current Ratio
5.123.563.633.674.47
Return On Assets (ROA)
20.90%31.75%20.47%14.29%20.83%
Return On Equity (ROE)
27.49%43.03%31.87%19.08%27.91%

All data in USD

Charts